Association of pembrolizumab with tumor response and survival among patients with advanced melanoma Academic Article uri icon

Overview

MeSH Major

  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Agents
  • Melanoma
  • Skin Neoplasms

abstract

  • clinicaltrials.gov Identifier: NCT01295827.

publication date

  • April 19, 2016

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1001/jama.2016.4059

PubMed ID

  • 27092830

Additional Document Info

start page

  • 1600

end page

  • 9

volume

  • 315

number

  • 15